https://orcid.org/0000-0001-6288-9915
Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
An-Sofie Schoonjans & Berten Ceulemans. (2022) A critical evaluation of fenfluramine hydrochloride for the treatment of Dravet syndrome. Expert Review of Neurotherapeutics 22:5, pages 351-364.
Read now
Read now
Ana Pejčić, Slobodan M. Janković, Miralem Đešević, Refet Gojak, Snežana Lukić, Nenad Marković & Miloš Milosavljević. (2021) Novel and emerging therapeutics for genetic epilepsies. Expert Review of Neurotherapeutics 21:11, pages 1283-1301.
Read now
Read now
Alberto Verrotti & Pasquale Striano. (2021) Novel therapeutic options for Dravet and Lennox-Gastaut syndrome. Expert Review of Neurotherapeutics 21:11, pages 1191-1194.
Read now
Read now
Adam Strzelczyk, Janina Grau, Thomas Bast, Astrid Bertsche, Ulrich Bettendorf, Andreas Hahn, Hans Hartmann, Christoph Hertzberg, Frauke Hornemann, Ilka Immisch, Julia Jacobs, Kerstin A. Klotz, Gerhard Kluger, Susanne Knake, Markus Knuf, Gerhard Kurlemann, Klaus Marquard, Thomas Mayer, Sascha Meyer, Hiltrud Muhle, Karen Müller-Schlüter, Felix von Podewils, Felix Rosenow, Susanne Ruf, Matthias Sauter, Hannah Schäfer, Jan-Ulrich Schlump, Susanne Schubert-Bast, Steffen Syrbe, Charlotte Thiels, Regina Trollmann, Adelheid Wiemer-Kruel, Bernd Wilken, Bianca Zukunft & Johann Philipp Zöllner. (2021) Prescription patterns of antiseizure drugs in tuberous sclerosis complex (TSC)-associated epilepsy: a multicenter cohort study from Germany and review of the literature. Expert Review of Clinical Pharmacology 14:6, pages 749-760.
Read now
Read now
Barbara Miziak & Stanisław Czuczwar. (2021) Advances in the design and discovery of novel small molecule drugs for the treatment of Dravet Syndrome. Expert Opinion on Drug Discovery 16:5, pages 579-593.
Read now
Read now
Articles from other publishers (35)
Robert Lersch, Rawan Jannadi, Leonie Grosse, Matias Wagner, Marius Frederik Schneider, Celina von Stülpnagel, Florian Heinen, Heidrun Potschka & Ingo Borggraefe. (2022) Targeted Molecular Strategies for Genetic Neurodevelopmental Disorders: Emerging Lessons from Dravet Syndrome. The Neuroscientist 29:6, pages 732-750.
Crossref
Crossref
Adam Strzelczyk, Lieven Lagae, Jo M Wilmshurst, Andreas Brunklaus, Pasquale Striano, Felix Rosenow & Susanne Schubert‐Bast. (2023) Dravet syndrome: A systematic literature review of the illness burden. Epilepsia Open 8:4, pages 1256-1270.
Crossref
Crossref
Margarita Maltseva, Felix Rosenow, Susanne Schubert‐Bast, Silke Flege, Markus Wolff, Sarah von Spiczak, Regina Trollmann, Steffen Syrbe, Susanne Ruf, Tilman Polster, Bernd A. Neubauer, Thomas Mayer, Julia Jacobs, Gerhard Kurlemann, Gerhard Kluger, Kerstin A. Klotz, Matthias Kieslich, Lara Kay, Frauke Hornemann, Ulrich Bettendorf, Astrid Bertsche, Thomas Bast & Adam Strzelczyk. (2023)
Critical incidents, nocturnal supervision, and caregiver knowledge on
SUDEP
in patients with Dravet syndrome: A prospective multicenter study in Germany
. Epilepsia.
Crossref
Crossref
Susanne Schubert-Bast, Moninder Kaur, Lars Joeres, Nadia Foskett, Robert Roebling & Adam Strzelczyk. (2023) Epidemiology of focal onset seizures in children aged >1 month to 4 years in Europe, United States, and Canada: A literature review. Seizure: European Journal of Epilepsy 112, pages 88-97.
Crossref
Crossref
Ashwini Sri Hari, Rajeswari Banerji, Li-Ping Liang, Ruth E. Fulton, Christopher Quoc Huynh, Timothy Fabisiak, Pallavi Bhuyan McElroy, James R. Roede & Manisha Patel. (2023) Increasing glutathione levels by a novel posttranslational mechanism inhibits neuronal hyperexcitability. Redox Biology 67, pages 102895.
Crossref
Crossref
Simona Lattanzi, Eugen Trinka, Emilio Russo, Cinzia Del Giovane, Sara Matricardi, Stefano Meletti, Pasquale Striano, Payam Tabaee Damavandi, Mauro Silvestrini & Francesco Brigo. (2023) Pharmacotherapy for Dravet Syndrome: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. Drugs 83:15, pages 1409-1424.
Crossref
Crossref
Jan Domaradzki & Dariusz Walkowiak. (2023) Emotional experiences of family caregivers of children with Dravet syndrome. Epilepsy & Behavior 142, pages 109193.
Crossref
Crossref
Margarita Maltseva, Susanne Schubert-Bast, Johann Philipp Zöllner, Thomas Bast, Thomas Mayer, Sarah von Spiczak, Susanne Ruf, Regina Trollmann, Markus Wolff, Frauke Hornemann, Kerstin A. Klotz, Julia Jacobs, Gerhard Kurlemann, Bernd A. Neubauer, Tilman Polster, Steffen Syrbe, Astrid Bertsche, Ulrich Bettendorf, Gerhard Kluger, Silke Flege, Felix Rosenow, Lara Kay & Adam Strzelczyk. (2023) Sleep quality, anxiety, symptoms of depression, and caregiver burden among those caring for patients with Dravet syndrome: a prospective multicenter study in Germany. Orphanet Journal of Rare Diseases 18:1.
Crossref
Crossref
Antonio Gil-Nagel, Rocío Sánchez-Carpintero & Vicente Villanueva. (2023) Patient profile, management, and quality of life associated with Dravet syndrome: a cross-sectional, multicentre study of 80 patients in Spain. Scientific Reports 13:1.
Crossref
Crossref
Adam Strzelczyk, Gerhard Kurlemann, Thomas Bast, Ulrich Bettendorf, Gerhard Kluger, Thomas Mayer, Bernd A. Neubauer, Tilman Polster, Sarah von Spiczak, Regina Trollmann, Markus Wolff, Toby Toward, Jens Gruenert, Eddie Gibson, Clive Pritchard, Joe Carroll, Felix Rosenow & Susanne Schubert-Bast. (2022) Exploring the relationships between composite scores of disease severity, seizure-freedom and quality of life in Dravet syndrome. Neurological Research and Practice 4:1.
Crossref
Crossref
Joseph Sullivan, Elaine Wirrell, Kelly G. Knupp, Dillon Chen, Muhammad Zafar, Robert Flamini, James Stutely, Charlene Brathwaite, Pam Ventola, Javier Avendaño, Kimberly A. Parkerson, Nancy Wyant & Barry Ticho. (2022) Interim results of adaptive functioning and neurodevelopment in BUTTERFLY – An observational study of children and adolescents with Dravet syndrome. Epilepsy & Behavior 137, pages 108955.
Crossref
Crossref
Jie Du, Xiaodong Chen, Yongshun Zhao, Tingting Zhao, Dalong Wang, Zujia Chen, Changyuan Wang, Qiang Meng, Jialin Yao, Huijun Sun, Kexin Liu & Jingjing Wu. (2022) Characterization of three naturally occurring lignans, sesamol, sesamolin, and sesamin, as potent inhibitors of human cytochrome P450 46A1: Implications for treating excitatory neurotoxicity. Frontiers in Pharmacology 13.
Crossref
Crossref
Adam Strzelczyk & Susanne Schubert-Bast. (2022) Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies. CNS Drugs 36:10, pages 1079-1111.
Crossref
Crossref
Juan Carlos Lopez, Jasmine R. Pare, Allison B. Blackmer & Lucas E. Orth. (2022) Treatment-Refractory Dravet Syndrome: Considerations for Novel Medications. Journal of Pediatric Health Care 36:5, pages 479-488.
Crossref
Crossref
Kishan Vyas, Hannah Luedke & Benjamin Ruban‐Fell. (2022) Nordic treatment guidelines for rare epileptic conditions: A literature review. Brain and Behavior 12:7.
Crossref
Crossref
Xue-Min Shi, Wen-Yan She, Ting-Ting Liu, Lian-Xun Gao, Yu-Jiao Liu & Yi Liu. (2022) 1,3-Benzodioxole Derivatives Improve the Anti-Tumor Efficiency of Arsenicals. International Journal of Molecular Sciences 23:13, pages 6930.
Crossref
Crossref
Toshiya Nishi, Cameron S. Metcalf, Shinji Fujimoto, Shigeo Hasegawa, Maki Miyamoto, Eiji Sunahara, Sayuri Watanabe, Shinichi Kondo & H. Steve White. (2022) Anticonvulsive properties of soticlestat, a novel cholesterol 24‐hydroxylase inhibitor. Epilepsia 63:6, pages 1580-1590.
Crossref
Crossref
A. Strzelczyk, L. Lagae, G. Kurlemann, S. Flege, T. Bast, T. Polster, M. Pringsheim, S. von Spiczak, P. Hipp & S. Schubert-Bast. (2021) Klinische Charakteristika und Lebensqualität beim Dravet-Syndrom: Ergebnisse der deutschen Kohorte des „Dravet syndrome caregiver survey“ (DISCUSS)Clinical characteristics and quality of life with Dravet syndrome: results of the German cohort of the Dravet syndrome caregiver survey (DISCUSS). Zeitschrift für Epileptologie 35:2, pages 169-177.
Crossref
Crossref
Jimmy Li, Dènahin Hinnoutondji Toffa, Maude Lefèbvre, Martine Tétreault, Patrick Cossette, Éric Samarut & Dang Khoa Nguyen. (2022) Usage of Genetic Panels in an Adult Epilepsy Clinic. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, pages 1-7.
Crossref
Crossref
Adam Strzelczyk & Susanne Schubert-Bast. (2022) A Practical Guide to the Treatment of Dravet Syndrome with Anti-Seizure Medication. CNS Drugs 36:3, pages 217-237.
Crossref
Crossref
Tatsuki Koike, Cristian C. Constantinescu, Shuhei Ikeda, Toshiya Nishi, Eiji Sunahara, Maki Miyamoto, Patricia Cole, Olivier Barret, David Alagille, Caroline Papin, Thomas Morley, Krista Fowles, John Seibyl, Gilles Tamagnan & Takanobu Kuroita. (2021) Preclinical characterization of [18F]T-008, a novel PET imaging radioligand for cholesterol 24-hydroxylase. European Journal of Nuclear Medicine and Molecular Imaging 49:4, pages 1148-1156.
Crossref
Crossref
Susanne Schubert-Bast, Lara Kay, Andreas Simon, Geoffrey Wyatt, Rowena Holland, Felix Rosenow & Adam Strzelczyk. (2022) Epidemiology, healthcare resource use, and mortality in patients with probable Dravet syndrome: A population-based study on German health insurance data. Epilepsy & Behavior 126, pages 108442.
Crossref
Crossref
Adam Strzelczyk, Katharina Frey, Felix Rosenow & Susanne Schubert-Bast. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
1
15
.
Adam Strzelczyk, Katharina Frey, Felix Rosenow & Susanne Schubert-Bast. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
3781
3795
.
Medo Gutic, Ardea Milidrag, Azra Gutic Cikotic, Milos Danilovic, Teodora Safiye, Ivana Bulatovic, Milos N. Milosavljevic & Slobodan Jankovic. (2021) Rare Neurological Diseases: an Overreview of Pathophysiology, Epidemiology, Clinical Features and Pharmacoeconomic Considerations in the Treating. Serbian Journal of Experimental and Clinical Research 0:0.
Crossref
Crossref
Antonella Riva, Alice Golda, Ganna Balagura, Elisabetta Amadori, Maria Stella Vari, Gianluca Piccolo, Michele Iacomino, Simona Lattanzi, Vincenzo Salpietro, Carlo Minetti & Pasquale Striano. (2021) New Trends and Most Promising Therapeutic Strategies for Epilepsy Treatment. Frontiers in Neurology 12.
Crossref
Crossref
Adam Strzelczyk, Milka Pringsheim, Thomas Mayer, Tilman Polster, Kerstin A. Klotz, Hiltrud Muhle, Michael Alber, Regina Trollmann, Hartwig Spors, Gerhard Kluger, Gerhard Kurlemann & Susanne Schubert‐Bast. (2021) Efficacy, tolerability, and retention of fenfluramine for the treatment of seizures in patients with Dravet syndrome: Compassionate use program in Germany. Epilepsia 62:10, pages 2518-2527.
Crossref
Crossref
Tatsuki Koike, Masato Yoshikawa, Haruhi Kamisaki Ando, William Farnaby, Toshiya Nishi, Etsurou Watanabe, Jason Yano, Maki Miyamoto, Shigeru Kondo, Tsuyoshi Ishii & Takanobu Kuroita. (2021) Discovery of Soticlestat, a Potent and Selective Inhibitor for Cholesterol 24-Hydroxylase (CH24H). Journal of Medicinal Chemistry 64:16, pages 12228-12244.
Crossref
Crossref
Agnieszka Matuszewska, Beata Nowak, Anna Nikodem, Anna Merwid-Ląd, Benita Wiatrak, Tomasz Tomkalski, Diana Jędrzejuk, Ewa Szeląg, Tomasz Sozański, Maciej Danielewski, Paulina Jawień, Ireneusz Ceremuga, Marta Szandruk-Bender, Marek Bolanowski, Jarosław Filipiak & Adam Szeląg. (2021) Antiepileptic Stiripentol May Influence Bones. International Journal of Molecular Sciences 22:13, pages 7162.
Crossref
Crossref
Aleksandr Shcheglovitov & Randall T. Peterson. (2021) Screening Platforms for Genetic Epilepsies—Zebrafish, iPSC-Derived Neurons, and Organoids. Neurotherapeutics 18:3, pages 1478-1489.
Crossref
Crossref
Adam Strzelczyk & Friedhelm C. Schmitt. (2021) Syndromspezifische Therapien, Impfung gegen Corona und Epileptologie in der DDRSyndrome-specific treatment, vaccination against coronavirus and epileptology in the GDR. Zeitschrift für Epileptologie 34:2, pages 129-131.
Crossref
Crossref
Yuan-Yuan Gao, Wen Tian, Hui-Nan Zhang, Yang Sun, Jing-Ru Meng, Wei Cao & Xiao-Qiang Li. (2021) Canonical transient receptor potential channels and their modulators: biology, pharmacology and therapeutic potentials. Archives of Pharmacal Research 44:4, pages 354-377.
Crossref
Crossref
A. Strzelczyk, L. Lagae, G. Kurlemann, S. Flege, T. Bast, T. Polster, M. Pringsheim, S. von Spiczak, P. Hipp & S. Schubert-Bast. (2021) Klinische Charakteristika und Lebensqualität beim Dravet-Syndrom: Ergebnisse der deutschen Kohorte des „Dravet syndrome caregiver survey“ (DISCUSS)Clinical characteristics and quality of life with Dravet syndrome: results of the German cohort of the Dravet syndrome caregiver survey (DISCUSS). Monatsschrift Kinderheilkunde.
Crossref
Crossref
Susanne Schubert-Bast & Adam Strzelczyk. (2021) Review of the treatment options for epilepsy in tuberous sclerosis complex: towards precision medicine. Therapeutic Advances in Neurological Disorders 14, pages 175628642110311.
Crossref
Crossref
Adam Strzelczyk & Susanne Schubert-Bast. (2021) Expanding the Treatment Landscape for Lennox-Gastaut Syndrome: Current and Future Strategies. CNS Drugs 35:1, pages 61-83.
Crossref
Crossref